Compare Johnson & Johnson (JNJ) vs Procter & Gamble Co (PG) Price & Performance

Johnson & JohnsonTrade

Procter & Gamble CoTrade

Price performance (Past 24H)

Key statistics

Johnson & Johnson vs Procter & Gamble Co — how do they compare? Johnson & Johnson trades at $251.13 (market cap $598.96B), while Procter & Gamble Co trades at $148.01 (market cap $347.26B). The key difference: Johnson & Johnson is the larger of the two by market cap, and Procter & Gamble Co pays the higher dividend (2.92%). Which is the better fit depends on your goals.

	JNJ	PG
Market Cap	$598.96B	$347.26B
Volume	6,156,228	6,423,436
Sector	Health	Consumer Staples
52-Week High	$267.24	$167.18
52-Week Low	$164.36	$138.10
Enterprise Value	$631.90B	$372.74B
Dividend Yield	2.15%	2.92%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Johnson & Johnson

No Aura AI signal available yet.

Procter & Gamble Co

Procter & Gamble (PG) trades at $148.19, down 1.18% on the day, as the consumer staples giant shows stable fundamentals with consistent earnings beats and strong dividend payments. The stock maintains a bullish technical signal with moving averages supporting upward momentum, while recent news highlights institutional positioning shifts and ongoing supply chain improvements. Revenue growth remains modest but stable at $84.28 billion for 2025, with net income margin improving to 19.16%.

PG offers defensive appeal with 69 consecutive years of dividend growth and premium valuation metrics. Upside potential exists toward the $161.71 analyst consensus target, though premium multiples and soft demand outlook present near-term headwinds. The stock remains a core holding for income investors seeking stability amid market volatility.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JNJ

Head and neck squamous cell carcinoma market to grow at 10.5% CAGR by 2036 driven by new immunotherapiesNa · 3 hours agoBullish 2025 tax law boosts US manufacturing jobs, wages, and growth across all 50 statesFox Business · 11 hours agoBullish DIVO ETF up 6.6% YTD but faces pressure from high Treasury yields and low volatility.24/7 Wall Street · 3 days agoNeutral View details →

DIVO ETF up 6.6% YTD but faces pressure from high Treasury yields and low volatility.24/7 Wall Street · 3 days agoNeutral Vanguard High Dividend Yield ETF offers durable income with strong dividend coverage and steady returns.24/7 Wall Street · 4 days agoBullish SPYI ETF yields 12% but faces pressure as volatility drops and Treasury yields rise.24/7 Wall Street · 4 days agoNeutral View details →

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.